These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36974260)

  • 1. Botulinum Toxin Injection for Masseteric Hypertrophy Using 6 Point Injection Technique - A Case Report. Proposal of a Clinical Technique to Quantify Prognosis.
    Rathod NN; John RS
    Clin Cosmet Investig Dent; 2023; 15():45-49. PubMed ID: 36974260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin for masseter hypertrophy.
    Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin for masseter hypertrophy.
    Fedorowicz Z; van Zuuren EJ; Schoones J
    Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD007510. PubMed ID: 24018587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter.
    Kaya B; Apaydin N; Loukas M; Tubbs RS
    J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):1663-8. PubMed ID: 25175271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of botulinum toxin type A in aesthetic mandibular contouring.
    Kim NH; Chung JH; Park RH; Park JB
    Plast Reconstr Surg; 2005 Mar; 115(3):919-30. PubMed ID: 15731696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A treatment for contouring of the lower face.
    Park MY; Ahn KY; Jung DS
    Dermatol Surg; 2003 May; 29(5):477-83; discussion 483. PubMed ID: 12752514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Botulinum Toxin in Treating Asian Indian Patients with Masseter Hypertrophy: A 4-Year Follow-Up Study.
    Shome D; Khare S; Kapoor R
    Plast Reconstr Surg; 2019 Sep; 144(3):390e-396e. PubMed ID: 31461011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
    Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q
    Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of masseter hypertrophy with botulinum toxin type A.
    Al-Ahmad HT; Al-Qudah MA
    Saudi Med J; 2006 Mar; 27(3):397-400. PubMed ID: 16532107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases.
    Baş B; Ozan B; Muğlali M; Celebi N
    Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e649-52. PubMed ID: 20173718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of two different units of botulinum toxin type a evaluated by computed tomography and electromyographic measurements of human masseter muscle.
    Kim JH; Shin JH; Kim ST; Kim CY
    Plast Reconstr Surg; 2007 Feb; 119(2):711-7. PubMed ID: 17230111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemodenervation with botulinumtoxin in masseteric hypertrophy].
    Mischkowski RA; Siessegger M; Lazar F; Zöller JE
    Mund Kiefer Gesichtschir; 2005 Mar; 9(2):101-8. PubMed ID: 15711991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Literature review of the adverse events associated with botulinum toxin injection for the masseter muscle hypertrophy.
    Yeh YT; Peng JH; Peng HP
    J Cosmet Dermatol; 2018 Oct; 17(5):675-687. PubMed ID: 30091170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the efficacy and safety of radiofrequency ablation and botulinum toxin A in treating masseteric hypertrophy.
    Huang JL; Chen G; Chen XD; Zhou BR; Luo D
    Exp Ther Med; 2014 May; 7(5):1203-1208. PubMed ID: 24940412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy.
    Arikan OK; Tan FU; Kendi T; Koc C
    J Otolaryngol; 2006 Feb; 35(1):40-3. PubMed ID: 16527016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between Conventional Blind Injections and Ultrasound-Guided Injections of Botulinum Toxin Type A into the Masseter: A Clinical Trial.
    Bae H; Kim J; Seo KK; Hu KS; Kim ST; Kim HJ
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of incobotulinumtoxinA in the management of the masseter using two different injection techniques.
    Nikolis A; Enright KM; Masouri S; Bernstein S; Antoniou C
    Clin Cosmet Investig Dermatol; 2018; 11():347-356. PubMed ID: 30034247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy.
    Ahn KY; Kim ST
    Plast Reconstr Surg; 2007 Nov; 120(6):1662-1666. PubMed ID: 18040203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of botulinum toxin type A on contouring of the lower face.
    Choe SW; Cho WI; Lee CK; Seo SJ
    Dermatol Surg; 2005 May; 31(5):502-7; discussion 507-8. PubMed ID: 15962731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement.
    Kim HJ; Yum KW; Lee SS; Heo MS; Seo K
    Dermatol Surg; 2003 May; 29(5):484-9. PubMed ID: 12752515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.